Email: sale1@zhrc-tech.com
Company Profile
--
Zhuhai Ruichuang Technology Development Co., Ltd. was established in 2000. Specializing in small bag packaging machinery, we are a technology-oriented manufacturer integrating R&D, production, sales and service.We have obtained numerous certifications, including “Software Enterprise”in 2009, “High-Tech Enter- prise Certificate”in 2016,“Zhuhai Outstanding Independent Brand Enterprise”and CE certification in 2017. In 2018, we were awarded “Intellectual Property Management System Certification”, “Advanced Unit of Zhuhai Science and Technology Innovation Enterprise”and “High-Tech Products in Guangdong Province”.We have a professional team of technicians, engineers, sales and after-sales service staff. We always pursue and uphold our corporate philosophy: precision, innovation, integrity and credibility.
Branded Ruichuang packaging machines cover five series: granule, powder, liquid, pill, and filling machines. Our machines fully comply with GMP production requirements.The electric cutting device we devel- oped has been granted national patents. Our rolling-bag cutting knife, round corner cutting knife, and double-row packaging machine have reached leading levels in China.They are widely used in pharmaceutical, food, chemical, pesticide and other industries. Many well-known domestic manufacturers choose our machines, including Baiyunshan Pharmaceutical, Wanglaoji, Zhongyi Pharmaceutical, Guangdong Zhong- sheng Pharmaceutical, etc.Our machines are also exported to Hong Kong, Macao, Europe, America, Singapore, Australia, Malaysia and other countries and regions.Ruichuang has earned an excellent reputation for its advanced technology, strict management, superior quality and perfect service.
We will provide the outstanding services at the technical consultation, product model selection, installation and debugging, technical training, and maintenance. We insist to make updated technology, better quality and better service for our customers.
second-class professor and chief physician |PhD supervisor and tenured professor
Enjoying the Special Allowance of the State Council Since 1973, the Institute of Neurology of Anhui University of Traditional Chinese Medicine has taken the lead in the domestic research on the clinical treatment of hepatolenticular degeneration with integrated Chinese and Western medicine. In the 40-year in-depth research, it has taken the lead in the domestic research on the etiology and pathology, pathogenesis, diagnostic classification, treatment and efficacy evaluation of hepatolenticular degeneration (WD). In-depth and systematic research, significant and creative results have been achieved, A set of perfect diagnosis and treatment system of WD is put forward.
· The first domestic dimercaptosulfonate high-dose impact treatment of WD; · The first domestic zinc gluconate treatment of WD; · The first domestic use of dimercaptosuccinate capsules for the treatment of WD;
· The first application of dimercaptosuccinate injection in the treatment of WD in China;
· The first series of research on the treatment of WD with traditional Chinese medicine in China;
· Published the first WD monograph Hepatolenticular Degeneration in China;
· Participated in the formulation of China's first "Guidelines for the Diagnosis and Treatment of Hepatolenticular Degeneration in China".
As of December 2012, 15,000 hepatolenticular degeneration patients from all over the country, including Taiwan and Hong Kong, and from the United States, Spain, France, Italy and other overseas countries have been treated, with a total effective rate of 91.16 per cent. Professor Fahn, vice chairman of the Parkinson's Disease Foundation of the United States, former deputy editor-in-chief of Neurology, and Professor Aposhian of Columbia University have made a special trip to our center to visit and exchange views on the treatment of hepatolenticular degeneration.
Dr Nan Cheng
Postdoctoral fellow, Hefei Institute of Material Science, Chinese Academy of Sciences |Professor | Doctoral Supervisor of Anhui University of Traditional Chinese Medicine
Member of Neurology Group of Neurology Branch of Chinese Medical Association, Member of Neurogenetics Group of Neurology Branch of Chinese Medical Doctor Association, Member of Molecular Diagnosis Expert Committee of Laboratory Medicine Professional Committee of Chinese Society of Integrated Traditional Chinese and Western Medicine, Mainly engaged in molecular diagnosis, treatment and related product research of Wilson disease (WD) and other neurogenetic diseases, presided over and participated in a number of national, provincial and ministerial research projects, the first large sample of Chinese WD epidemiological investigation and research was carried out. Based on MASS-ARRAY and NGS platforms, the gene mutations of more than 4000 WD patients were detected successively, and the most accurate WD gene mutation spectrum of Chinese was obtained. More than 50 papers were published in domestic and foreign journals, including 12 SCI/El papers, and 4 national invention patents were authorized.
Professor Mao Chuanbin
Professor, University of Oklahoma | Berkeley State Key Laboratory Visiting Research Institute | Member, University of Oklahoma Cancer Center
areas focus on phage display technology, biomolecular materials, cell-material interactions, cell engineering, tissue engineering, bio-nanotechnology, and nanomedicine. So far, about 110 papers have been published, some of which have been published in internationally renowned journals such as Science, PNAS, Angewandte Chemie International Edition, Journal of theAmerican Chemical Society and Advanced Materials. He was awarded the only New Scientist Award of Oklahoma Science and Technology Innovation Research Center in 2006, the ConceptAward of the US Department of Defense Breast Cancer Research Program in 2007, the CAREER Award of the US National Natural Science Foundation in 2009, the Junior Faculty Award, Distinguished of the Sino-US Association of Chemistry and Chemical Biology Professors in 2010, and the DiscoveryAward of the US Department of Defense Medical Research Program in 2012. He is currently the SeniorAssociateEditor of SCI International Journal Microscopy Research and Technique published by Wiley, and the editorial board of 4 international journals. Participate in fund reviews in the United States and other countries around the world.
Dr. Xia Yi
engaged in intelligent car, detection technology, machine vision and other direction of research work. The main courses are "Analog Electronic Technology Foundation", "Smart Car Technology", "Engineering Optics" and so on. Participated in 3 key projects of national fund and provincial fund, presided over 1 research project of Anhui University Youth Fund, published more than 20 papers in academic journals at home and abroad (including 15 in SCI), and won 5 invention patents. The main research directions are non-stationary signal processing, image processing and understanding, pattern recognition and deep learning.
Enterprise management purpose
Fine (precision), new (innovation), honesty (honesty), letter (Cino), carry forward the spirit of craftsmanship, to achieve excellence.
Business philosophy
Seek market by quality, seek development by innovation, seek cooperation by integrity. Professional to provide technical advice, program design, production and sales, after-sales one-stop service to
Win-win cooperation
--
Contact Us
Address: Room 502, Building 1, No. 300 Xinsha 3rd Road, High-tech Zone, Zhuhai City, Guangdong Province
Phone: 0756-2296815/2296126
Email: sale1@zhrc-tech.com
Copyright © Zhuhai Ruichuang Technology Development Co., Ltd.
Fllow Us